Bicocca Open Archive

Logo unimib boa
ROMERIO, ALESSIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 5.828
AS - Asia 2.339
NA - Nord America 2.145
SA - Sud America 278
Continente sconosciuto - Info sul continente non disponibili 125
AF - Africa 53
OC - Oceania 27
Totale 10.795
Salva come PNG Salva come JPEG
Nazione #
SE - Svezia 3.759
US - Stati Uniti d'America 2.035
IT - Italia 1.061
SG - Singapore 561
VN - Vietnam 560
CN - Cina 377
DE - Germania 298
HK - Hong Kong 211
BR - Brasile 199
RU - Federazione Russa 173
IN - India 137
KR - Corea 95
GB - Regno Unito 91
FR - Francia 87
BD - Bangladesh 81
CA - Canada 68
NL - Olanda 66
JP - Giappone 57
ID - Indonesia 54
ES - Italia 52
PL - Polonia 43
IE - Irlanda 42
FI - Finlandia 34
PK - Pakistan 31
AR - Argentina 27
IR - Iran 27
AU - Australia 26
MX - Messico 23
BE - Belgio 22
IQ - Iraq 22
ZA - Sudafrica 21
TR - Turchia 20
DK - Danimarca 17
AT - Austria 14
CO - Colombia 14
UA - Ucraina 14
MY - Malesia 13
SA - Arabia Saudita 13
PH - Filippine 12
EC - Ecuador 11
CL - Cile 10
LT - Lituania 10
UZ - Uzbekistan 10
CH - Svizzera 9
MA - Marocco 8
PT - Portogallo 8
TW - Taiwan 8
IL - Israele 7
PY - Paraguay 6
VE - Venezuela 6
AE - Emirati Arabi Uniti 5
AZ - Azerbaigian 5
GR - Grecia 5
JO - Giordania 5
AL - Albania 4
CR - Costa Rica 4
CZ - Repubblica Ceca 4
EG - Egitto 4
ET - Etiopia 4
KZ - Kazakistan 4
LB - Libano 4
NG - Nigeria 4
NP - Nepal 4
DO - Repubblica Dominicana 3
GA - Gabon 3
JM - Giamaica 3
TN - Tunisia 3
AM - Armenia 2
BB - Barbados 2
KE - Kenya 2
KH - Cambogia 2
MK - Macedonia 2
NI - Nicaragua 2
NO - Norvegia 2
OM - Oman 2
PA - Panama 2
PE - Perù 2
RO - Romania 2
SI - Slovenia 2
SK - Slovacchia (Repubblica Slovacca) 2
TH - Thailandia 2
A1 - Anonimo 1
BG - Bulgaria 1
BO - Bolivia 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
CY - Cipro 1
DZ - Algeria 1
GE - Georgia 1
GT - Guatemala 1
GY - Guiana 1
HU - Ungheria 1
KG - Kirghizistan 1
LA - Repubblica Popolare Democratica del Laos 1
LV - Lettonia 1
LY - Libia 1
MD - Moldavia 1
MM - Myanmar 1
MO - Macao, regione amministrativa speciale della Cina 1
MU - Mauritius 1
Totale 10.665
Salva come PNG Salva come JPEG
Città #
Stockholm 3.728
Milan 380
Singapore 337
Frankfurt am Main 252
Ashburn 239
San Jose 235
Ho Chi Minh City 184
Hong Kong 182
Hanoi 131
Council Bluffs 100
Los Angeles 96
Ann Arbor 90
Hefei 70
Rome 62
New York 60
Beijing 53
Seoul 50
Dallas 48
Santa Clara 48
Jakarta 43
Columbus 42
Dublin 42
Chicago 41
Tokyo 40
Boardman 36
São Paulo 33
Buffalo 31
Toronto 29
Turin 29
Amsterdam 28
Chandler 28
Jeju City 27
Florence 24
Bologna 23
Phoenix 23
Hyderabad 22
Shanghai 22
Helsinki 21
London 20
Maastricht 20
Naples 20
Houston 19
Atlanta 18
Brisbane 18
Warsaw 18
Can Tho 16
Da Nang 16
Sassuolo 16
Chennai 15
Lauterbourg 15
Madison 15
New Delhi 15
Orem 15
Paris 15
The Dalles 15
Figino 14
Johannesburg 14
Montreal 14
Philadelphia 14
Brescia 13
Brooklyn 13
Copenhagen 13
Ha Long 13
Biên Hòa 12
Denver 12
Monza 12
San Giuliano Terme 12
Boston 11
Haiphong 11
Moscow 11
Baghdad 10
Hải Dương 10
Poplar 10
Seattle 10
Tashkent 10
Kent 9
Lahore 9
Lappeenranta 9
Nuremberg 9
Vienna 9
Washington 9
Austin 8
Brussels 8
Cerdanyola del Vallès 8
Como 8
Desio 8
Medellín 8
Mexico City 8
Munich 8
Princeton 8
Quận Bình Thạnh 8
San Francisco 8
Barnet 7
Cedar Rapids 7
Guangzhou 7
Hangzhou 7
Huế 7
Istanbul 7
Karachi 7
Krakow 7
Totale 7.652
Salva come PNG Salva come JPEG
Nome #
Representative secondary PET micro and nanoplastics via ethylene glycol fragmentation (EGF): Physicochemical and immuno-toxicological properties 2.030
Validating Natural Compounds as Toll-Like Receptor 4 (TLR4) Antagonists: Experimental Challenges and Therapeutic Perspectives 1.947
Synthesis and Biological Characterization of TLR4 Agonists as Innovative Vaccine Adjuvants 832
NEW SYNTHETIC AGONISTS OF TLR4 RECEPTOR 507
Vibrational spectroscopy coupled with machine learning sheds light on the cellular effects induced by rationally designed TLR4 agonists 413
Highly Selective SERCA2a Activators: Preclinical Development of a Congeneric Group of First-in-Class Drug Leads against Heart Failure 381
Synthetic Glycolipids as Molecular Vaccine Adjuvants: Mechanism of Action in Human Cells and in Vivo Activity 353
Potentiation of fluoroquinolone and macrolide activities by efflux pump inhibitory effect on Staphylococcus aureus and Streptococcus pyogenes of new benzyl piperazinyl lysine derivatives 337
Increasing the Chemical Variety of Small-Molecule-Based TLR4 Modulators: An Overview 333
New Glucosamine-Based TLR4 Agonists: Design, Synthesis, Mechanism of Action, and In Vivo Activity as Vaccine Adjuvants 306
Study on the impact of Toll-like Receptor 4 (TLR4) modulation in rare inflammatory-fibrotic diseases 299
Design, Synthesis and characterization of synthetic and natural derived TLR4 antagonists 287
Impact of Toll-like Receptor 4 (TLR4) chemical modulation by small- molecular antagonists in rare inflammatory-fibrotic diseases 287
Towards more efficient synthetic immunomodulators: biological characterization and mechanism of action of monosaccharide-derived TLR4 agonists 281
Novel TLR4-Activating Vaccine Adjuvant Enhances the Production of Enterococcus faecium-binding Antibodies 257
Development of a New Vaccine Adjuvant System Based on the Combination of the Synthetic TLR4 Agonist FP20 and a Synthetic QS-21 Variant 240
Overcoming Challenges in Chemical Glycosylation to Achieve Innovative Vaccine Adjuvants Possessing Enhanced TLR4 Activity 236
Cleaner synthesis of preclinically validated vaccine adjuvants 187
Preclinical development of the TLR4 antagonist FP12 as a drug lead targeting the HMGB1/MD-2/TLR4 axis in lethal influenza infection 183
Monosaccharide-Based Synthetic TLR4 Agonist Enhances Vaccine Efficacy against Pseudomonas aeruginosa Challenge 180
Study on the impact of Toll-like Receptor 4 (TLR4) modulation in rare inflammatory-fibrotic diseases 152
Functional impact of Toll-like Receptor 4 (TLR4) modulation in lung fibrosis-associated fibroblasts 148
Developing New Toll-Like Receptor 4 (TLR4) Modulators As Innovative And Inexpensive Vaccine Adjuvants 87
Developing New Toll-Like Receptor 4 (TLR4) Modulators as Innovative and Inexpensive Vaccine Adjuvants 70
DESIGN, SYNTHESIS AND BIOLOGICAL EVALUATION OF NEW, GLYCOLIPID-BASED TOLL-LIKE RECEPTOR 4 (TLR4) MODULATORS 67
Design, Synthesis and Biological Evaluation of New Glycolipid-Based Toll-Like Receptor 4 (TLR4) Modulators 66
Design, synthesis and Biological evaluation of New, glycolipid-based Toll-Like Receptor 4 (TLR4) Modulators 56
Design, synthesis and Biological evaluation of New, glycolipid-based Toll-Like Receptor 4 (TLR4) Modulators 55
NEW SMALL MOLECULES AS TLR4 MODULATORS: SYNTHESIS AND BIOLOGICAL CHARACTERIZATION 54
Design, synthesis and Biological evaluation of New, glycolipid-based Toll-Like Receptor 4 (TLR4) Modulators 52
Design, synthesis and Biological evaluation of New, glycolipid-based Toll-Like Receptor 4 (TLR4) Modulators 48
Design, synthesis and biological evaluation of a new Toll Like Receptor 4 agonist-based Antibody Drug Conjugate for cancer immunotherapy. 23
Design, synthesis and biological evaluation of a new Toll Like Receptor 4 agonist-based Antibody Drug Conjugate for cancer immunotherapy. 15
Design and synthesis of a new Toll Like Receptor 4 agonist-based Antibody Drug Conjugate for cancer immunotherapy 14
Design, synthesis and biological evaluation of a new Toll Like Receptor 4 agonist-based Antibody Drug Conjugate for cancer immunotherapy. 12
Totale 10.795
Salva come PNG Salva come JPEG
Categoria #
all - tutte 23.554
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 23.554
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022118 0 0 0 0 0 0 0 28 14 12 16 48
2022/2023501 43 58 42 35 51 50 12 88 21 42 26 33
2023/2024536 52 19 39 31 52 65 44 23 53 42 42 74
2024/20251.451 70 89 120 101 104 76 77 64 131 194 148 277
2025/20267.530 557 251 225 404 320 164 392 184 346 4.197 155 335
2026/2027659 207 201 251 0 0 0 0 0 0 0 0 0
Totale 10.795